Suzuki, Yuko
Kan, Motoyasu
Kimura, Gen
Umemoto, Kumiko
Watanabe, Kazuo
Sasaki, Mitsuhito
Takahashi, Hideaki
Hashimoto, Yusuke
Imaoka, Hiroshi
Ohno, Izumi
Mitsunaga, Shuichi
Ikeda, Masafumi http://orcid.org/0000-0002-4050-2086
Article History
Received: 10 August 2018
Accepted: 1 October 2018
First Online: 8 October 2018
Compliance with ethical standards
:
: Masafumi Ikeda has received honoraria from Bayer Yakuhin, Ltd., Taiho Pharmaceutical Co., Ltd., Novartis Pharma K.K., Bristol-Myers Squibb, and Eli Lilly Japan K.K., and received commercial research funding from Ono Pharmaceutical Co., Ltd., AstraZeneca K.K., Zeria Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Merck Serono, Bayer Yakuhin, Ltd., YakltHonsha Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Baxter, ASLAN Pharmaceuticals, Nano Carrier Co., Ltd., and Chugai Pharmaceutical Co., Ltd.